Skip to main content
. 2021 Sep 4;12(4):1723–1739. doi: 10.1016/j.apsb.2021.08.030

Figure 8.

Figure 8

Schematic diagram of this HTS method and bioactivity validation of Aβ binding small molecules from natural medicines. (1) BLI analysis by Octet® RED96e system. (2) Identification by UHPLC−DAD-Q/TOF-MS/MS. (3) Isolation of the target ingredients from natural medicines. (4) Bioactivity validation of the screened Aβ binding small-molecules in vitro and in vivo.